INmune Bio Correlations
INMB Stock | USD 8.31 1.12 15.58% |
The current 90-days correlation between INmune Bio and Anixa Biosciences is 0.18 (i.e., Average diversification). The correlation of INmune Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
INmune Bio Correlation With Market
Average diversification
The correlation between INmune Bio and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and DJI in the same portfolio, assuming nothing else is changed.
INmune |
Moving together with INmune Stock
0.71 | DMAC | DiaMedica Therapeutics | PairCorr |
0.76 | VALN | Valneva SE ADR | PairCorr |
0.79 | VERV | Verve Therapeutics | PairCorr |
0.86 | VIGL | Vigil Neuroscience | PairCorr |
0.7 | SRZNW | Surrozen Warrant | PairCorr |
0.83 | VRNA | Verona Pharma PLC | PairCorr |
0.63 | VRTX | Vertex Pharmaceuticals | PairCorr |
Moving against INmune Stock
0.86 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
0.78 | VKTX | Viking Therapeutics | PairCorr |
0.74 | DSGN | Design Therapeutics Potential Growth | PairCorr |
0.65 | VERA | Vera Therapeutics | PairCorr |
0.57 | DRRX | Durect Earnings Call This Week | PairCorr |
0.52 | ME | 23Andme Holding | PairCorr |
0.5 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.47 | CDIOW | Cardio Diagnostics | PairCorr |
0.68 | VTYX | Ventyx Biosciences | PairCorr |
0.67 | VTRS | Viatris | PairCorr |
0.64 | DYAI | Dyadic International Earnings Call This Week | PairCorr |
0.56 | VYGR | Voyager Therapeutics | PairCorr |
0.55 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.5 | VYNE | Vyne Therapeutics | PairCorr |
0.43 | VRDN | Viridian Therapeutics | PairCorr |
0.38 | ELAN | Elanco Animal Health | PairCorr |
0.37 | VRAX | Virax Biolabs Group | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between INmune Stock performing well and INmune Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze INmune Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TFFP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ANEB | 5.34 | 0.59 | 0.10 | 0.35 | 5.29 | 19.58 | 40.87 | |||
ABCM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ANTX | 2.46 | (0.01) | 0.00 | (0.12) | 0.00 | 5.41 | 17.09 | |||
CUE | 4.93 | 0.04 | 0.00 | (0.04) | 0.00 | 8.51 | 38.78 | |||
ANIX | 3.36 | 0.27 | 0.06 | 0.12 | 3.77 | 7.14 | 26.44 | |||
INAB | 4.85 | (0.19) | 0.00 | (0.36) | 0.00 | 11.54 | 32.12 | |||
PYPD | 4.28 | 0.32 | 0.05 | 0.20 | 5.70 | 10.62 | 41.24 | |||
AVTE | 1.30 | (0.04) | 0.00 | (0.22) | 0.00 | 2.07 | 10.45 | |||
ELYM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
INmune Bio Corporate Management
Christopher Barnum | Head Neuroscience | Profile | |
BSc FRCPath | Chief Officer | Profile | |
Raymond MD | President, CoFounder | Profile | |
Joshua Esq | General Counsel | Profile | |
David MBA | Treasurer CFO | Profile |